North America
The North America Natural Killer Cells Therapeutics Market is expanding rapidly, driven by advancements in immunotherapy and increasing research activities in the field of cancer treatment. The United States is the leading country, with a strong focus on clinical trials and innovative therapeutic approaches that harness the power of natural killer (NK) cells....
The Natural Killer Cells market is estimated to be valued at US$ 132.76 Mn in 2023 and is expected to exhibit a CAGR of 44% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Natural killer cells (NK cells) are a type of cytotoxic lymphocyte critical to the innate immune system. NK cells provide rapid responses to virally...
NK cells are identified by the presence of surface receptors that allow them to recognize cells that are under stress or have been infected with a virus. These receptors include killer cell immunoglobulin-like receptors (KIRs), natural cytotoxicity receptors (NCRs), and NKG2D. Once an NK cell has identified a target cell, it can kill it through several mechanisms, including the release of...
Recent advances in immunotherapy have led to the development of NK cell-based cancer treatments that aim to harness the potential of these cells to kill cancer cells. NK cells can be isolated from the patient's blood or from a donor and expanded in the laboratory before being infused back into the patient. This approach, known as adoptive NK cell therapy, has shown promising results in clinical...